Curbing misconduct in the pharmaceutical industry: Insights from behavioral ethics and the behavioral approach to law

Journal of Law, Medicine and Ethics

Volumn 41, Issue 3, 2013, Pages 620-628

  Feldman, Yuval ^a   Gauthier, Rebecca ^b   Schuler, Troy ^c  

^a BAR ILAN UNIVERSITY   (Israel)

^b MOUNT HOLYOKE COLLEGE   (United States)

^c YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DRUG INDUSTRY; ETHICS; HUMAN; LEGAL ASPECT; PERSONNEL; RESEARCH ETHICS; SCIENTIFIC MISCONDUCT;

DRUG INDUSTRY; ETHICS, RESEARCH; HUMANS; RESEARCH PERSONNEL; SCIENTIFIC MISCONDUCT;

EID: 84885151384     PISSN: 10731105     EISSN: 1748720X     Source Type: Journal    
DOI: 10.1111/jlme.12071     Document Type: Article

References (35)

1. J. Miller, "On Restoring Trust and Ethics in Pharma, " available at (last visited June 10, 2013).
2. M. A. Rodwin, "Conflicts of Interest, Institutional Corruption, and Pharma: An Agenda for Reform, " Journal of Law, Medicine & Ethics 40, no. 3 (2012): 511-522.
3. M. Bazerman and A. Tenbrunsel, Blind Spots: Why We Fail to Do What's Right and What to Do about It (Princeton University Press, 2011): at 153-173;
4. M. Bazerman and B. Mahzarin "The Social Psychology of Ordinary Ethical Failures,"Social Justice Research 17, no. 2 (2004): 111-115.
5. Y. Feldman and O. Lobel, "The Incentives Matrix: The Comparative Effectiveness of Rewards, Liabilities, Duties, and Protections for Reporting Illegality, " Texas Law Review 88, no. 6 (2010): 1151-1211.
6. P. O'Leary, "Credible Deterrence: The Park Doctrine and the FDA in the 21st Century, " (forthcoming, Food and Drug Law Journal 68, no. 2). See, also, Gagnon, supra note 4.
7. A. Lam, "What Motivates Academic Scientists to Engage in Research Commercialization: 'Gold', 'Ribbon' or 'Puzzle'?" Research Policy 40, no. 10 (2011): 1354-1368.
8. D. Kahneman, Thinking, Fast and Slow (New York : Farrar, Straus and Giroux, 2011): at 20-21; K. Stanovich and R. West, "Individual Differences in Reasoning: Implications for the Rationality Debate?"Behavioral and Brain Sciences 23, no. 5 (2000): 645-665; JSBT Evans, "In Two Minds: Dual-Process Accounts of Reasoning, "Trends in Cognitive Sciences 7, no. 10 (2003): 454-459.
9. J. Haidt, "The Emotional Dog and Its Rational Tail: A Social Intuitionist Approach to Moral Judgment, " Psychological Review 108, no. 4 (2001): 814-834; J. Haidt and C. Joseph, "Intuitive Ethics: How Innately Prepared Intuitions Generate Culturally Variable Virtues, "Daedalus 133, no. 4 (2004): 55-66.
10. D. Langevoort, "Resetting the Corporate Thermostat: Lessons from the Recent Financial Scandals about Self-Deception, Deceiving Others and the Design of Internal Controls, " Georgetown Law Journal 93, no. 1 (2004): 285-317
11. K. Greenfield, quot;Using Behavioral Economics to Show the Power and Efficiency of Corporate Law as Regulatory Tool,"UC Davis Law Review 35, no. 3 (2001): 581-644
12. S. Sah and A. Fugh-Berman, "Physicians Under the Influence: Social Psychology and Industry Marketing Strategies, "Journal of Law, Medicine & Ethics 41, no. 3 (2013): 665-672.
13. Z. Kunda, "Motivated Inference: Self-Serving Generation and Evaluation of Causal Theories, " Journal of Personality and Social Psychology 53, no. 4 (1987): 636-647; Z. Kunda, "The Case for Motivated Reasoning, "Psychological Bulletin 108, no. 3 (1990): 480-498.
14. L. L. Shu and F. Gino, "Sweeping Dishonesty under the Rug: How Unethical Actions Lead to Forgetting of Moral Rules, " Journal of Personal Social Psychology 102, no. 6 (2012): 1164-1177
15. E. Balcetis and D. Dunning. "See What You Want to See: Motivational Influences on Visual Perception,"Journal of Personality and Social Psychology 91, no. 4 (2006): 612-625.
16. A. Bandura, "Moral Disengagement in the Perpetration of Inhumanities, " Personality and Social Psychology Review 3, no. 3 (1999): 193-209
17. C. Moore, quot;Why Employees Do Bad Things: Moral Disengagement and Unethical Organizational Behavior,"Personnel Psychology 65, no. 1 (2012): 1-48.
18. N. Mazar, O. Amir, and D. Ariely, "The Dishonesty of Honest People: A Theory of Self-Concept Maintenance, " Journal of Marketing Research 45, no. 6 (2008): 633-644;
19. D. Ariely, The Honest Truth about Dishonesty: How We Lie to Everyone - Especially Ourselves (New York: Harper, 2012).
20. U. Gneezy and A. Rustichini, "Fine Is a Price, " Journal of Legal Studies 29, no. 1 (2000): 1-28.
21. A. Tenbrunsel and D. Messick, "Sanctioning Systems, Decision Frames, and Cooperation, " Administrative Science Quarterly 44, no. 4 (1999): 684-707.
22. Y. Feldman and O. Perez, "How Law Changes the Environmental Mind: An Experimental Study of the Effect of Legal Norms on Moral Perceptions and Civic Enforcement, "Journal of Law and Society 36, no. 4 (2009): 501-535
23. Y. Feldman and O. Perez, "Motivating Environmental Action in a Pluralistic Regulatory Environment: An Experimental Study of Framing, Crowding Out, and Institutional Effects in the Context of Recycling Policies, "Law & Society Review 46, no. 2 (2012): 405-442.
24. M. Kouchaki et al., "Seeing Green: Mere Exposure to Money Triggers a Business Decision Frame and Unethical Outcomes, " Organizational Behavior and Human Decision Processes 121, no. 1 (2013): 53-61.
25. E. Fehr and S. Gächter, "Do Incentive Contracts Crowd Out Voluntary Cooperation?" Institute for Empirical Research in Economics University of Zurich, working paper no. 34 (2001): 1-46.
26. L. Lessig, Republic, Lost: How Money Corrupts Congress - and a Plan to Stop It (New York : Twelve, 2011); K. Vohs, N. Mead, and M. Goode, "The Psychological Consequences of Money, "Science 314, no. 5802 (2006): 1154-1156;
27. K. Vohs, N. Mead, and M. Goode, quot;Merely Activating the Concept of Money Changes Personal and Interpersonal Behavior,"Current Directions in Psychological Science 17, no. 3 (2008): 208-212.
28. See Y. Feldman, "The Complexity of Disentangling Intrinsic and Extrinsic Compliance Motivations: Theoretical and Empirical Insights from the Behavioral Analysis of Law, "Washington University Journal of Law and Policy 35, no. 1 (2011): 11-51.
29. M. Bazerman, G. Loewenstein, and D. A. Moore, "Why Good Accountants Do Bad Audits, " Harvard Business Review 80, no. 11 (2002): 96-103
30. M. A. Rodwin, "Independent Clinical Trials to Test Drugs: The Neglected Reform, "Saint Louis University Journal of Health Law & Policy 6, no. 1 (2012): 113-166
31. M. A. Rodwin, "Independent Clinical Trials to Test Drugs: The Neglected Reform, " Saint Louis University Journal of Health Law & Policy 6 (2012): 113-166.
32. See Bazerman and Tenbrunsel, supra note 6.
33. It should be noted, however, that other research finds that requiring some disclosures ahead of time may actually serve to encourage unethical behavior later on. D. M. Cain, G. Loewenstein, and D. A. Moore, "The Dirt on Coming Clean: Perverse Effects of Disclosing Conflicts of Interest, "Journal of Legal Studies 34, no. 1 (2005): 1-25.
34. Pharmaceutical Research and Manufacturers of America, Principles on Conduct of Clinical Trials Communication of Clinical Trial Results (2011).
35. J. Bard, "What to Do When You Can't Hear the Whistleblowing: A Proposal to Protect the Public's Health by Providing Whistleblower Protection for Medical Researchers, " Indiana Health Law Review 9, no. 1 (2011): 1-96.